Publication:
Thymoquinone administration ameliorates Alzheimer-s disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta(1-42) infused rat model

dc.contributor.authorELİBOL, BİRSEN
dc.contributor.authorBeker, Merve
dc.contributor.authorTerzioglu-Usak, Sule
dc.contributor.authorDalli, Tugce
dc.contributor.authorKilic, Ulkan
dc.contributor.institutionauthorELİBOL, BİRSEN
dc.contributor.institutionauthorBEKER, MERVE
dc.contributor.institutionauthorTERZİOĞLU, ŞULE
dc.date.accessioned2020-11-19T21:06:26Z
dc.date.available2020-11-19T21:06:26Z
dc.date.issued2020-12-01T00:00:00Z
dc.description.abstractBackground: Thymoquinone (TQ), a biologically active ingredient of Nigella sativa, has anti-inflammatory, antioxidative and neuroprotective properties. Therefore, it could be a good candidate in the recovery of Alzheimer-s disease (AD) pathology rather than current symptomatic reliefs.
dc.description.sponsorshipBezmiâlem Vakıf Üniversitesi
dc.identifier.citationELİBOL B., Beker M., Terzioglu-Usak S., Dalli T., Kilic U., -Thymoquinone administration ameliorates Alzheimer-s disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta(1-42) infused rat model-, PHYTOMEDICINE, cilt.79, 2020
dc.identifier.doi10.1016/j.phymed.2020.153324
dc.identifier.pubmed32920292
dc.identifier.scopus85090407332
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27389
dc.identifier.wosWOS:000581562000006
dc.titleThymoquinone administration ameliorates Alzheimer-s disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta(1-42) infused rat model
dc.typeArticle
dspace.entity.typePublication
local.avesis.id675b198d-e60c-47f4-b2b0-457002fd0cb9
local.publication.isinternational1
relation.isAuthorOfPublication1b1887fb-6b32-44b1-9d9f-416616dc6734
relation.isAuthorOfPublication6f8a3a29-68af-47b4-b206-bbc6051b00f5
relation.isAuthorOfPublicatione9c5ccbe-e102-4178-b519-106941fe5827
relation.isAuthorOfPublication.latestForDiscovery6f8a3a29-68af-47b4-b206-bbc6051b00f5
Files